Literature DB >> 17569124

Clinical features of familial adenomas polyps in Chinese and establishment of its immortal lymphocyte cell lines.

Shan-Rong Cai1, Su-Zhang Zhang, Shu Zheng.   

Abstract

AIM: To reserve the rare Chinese familial adenomas polyp (FAP) family resource and to investigate the clinical features of FAP in Chinese for its diagnosis.
METHODS: Clinical features of patients with FAP were investigated. If there is any question, their medical records were verified. Blood sample was taken and lymphocyte immortal cell lines were established with modified EB-transformation methods. Congenital hypertrophy of retinal pigment epithelium (CHRPE) was checked by an experienced ophthalmologist.
RESULTS: Twenty seven families including 21 classical FAP (CFAP) families, 3 attenuated FAP (AFAP) families, and 3 suspected AFAP families were investigated. A total of 116 lymphocyte immortal cell lines were established from 26 families. In all the FAP families, colorectal cancer occurred at the mean age of 42.84 years. Of the 16 families checked, 15 (93.75%) had CHRPE. The mean number of patients suffering from colorectal neoplasm was 3.14 in CFAP families and 2.0 in AFAP families (P<0.01). The mean oldest age at diagnosis of FAP was 41.75 years in CFAP families, and 58.67 years in AFAP families, respectively (P<0.01). Mean age of development of colorectal cancer was 42.23 in CFAP and 57.33 years old in AFAP (P<0.01). Mean of the earliest age at diagnosis of FAP was 29.95 years in the FAP families with a positive family history and 46.80 years in the FAP families with a negative family history (P < 0.01). The ratio of extra-intestinal tumors to colorectal neoplasms was different in the two kinds of families with positive and negative family history (P<0.01).
CONCLUSION: Additional use of ciclosporin will effectively improve to establish lymphocyte immortal cell lines with modified EB- transformation methods. In Chinese FAP, there was a high frequency of CHRPE , and a later age at diagnosis and a later age of development of colorectal cancer in AFAP. And earlier age at diagnosis in FAP with positive family history was also found that will help to diagnose various kinds of FAP in Chinese.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569124      PMCID: PMC4395640          DOI: 10.3748/wjg.v13.i20.2858

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Classification of familial adenomatous polyposis: a diagnostic nightmare.

Authors:  H T Lynch; T C Smyrk
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 2.  The genetics of colorectal cancer.

Authors:  J R Howe; J G Guillem
Journal:  Surg Clin North Am       Date:  1997-02       Impact factor: 2.741

3.  Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.

Authors:  H T Lynch; T Smyrk; T McGinn; S Lanspa; J Cavalieri; J Lynch; S Slominski-Castor; M C Cayouette; I Priluck; M C Luce
Journal:  Cancer       Date:  1995-12-15       Impact factor: 6.860

4.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

5.  Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Authors:  Rosario Touriño; Rogelio Conde-Freire; José M Cabezas-Agrícola; Teresa Rodríguez-Aves; Maria Jesús López-Valladares; José L Otero-Cepeda; Carmen Capeans
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

6.  Alleles of the APC gene: an attenuated form of familial polyposis.

Authors:  L Spirio; S Olschwang; J Groden; M Robertson; W Samowitz; G Joslyn; L Gelbert; A Thliveris; M Carlson; B Otterud
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

Review 7.  Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.

Authors:  Masanobu Sugimoto; Hidetoshi Tahara; Toshinori Ide; Yasuhiro Furuichi
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.